These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11876716)

  • 1. The effects of the specific 5HT(4) receptor agonist, prucalopride, on colonic motility in healthy volunteers.
    De Schryver AM; Andriesse GI; Samsom M; Smout AJ; Gooszen HG; Akkermans LM
    Aliment Pharmacol Ther; 2002 Mar; 16(3):603-12. PubMed ID: 11876716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of prucalopride on colonic transit, anorectal function and bowel habits in patients with chronic constipation.
    Sloots CE; Poen AC; Kerstens R; Stevens M; De Pauw M; Van Oene JC; Meuwissen SG; Felt-Bersma RJ
    Aliment Pharmacol Ther; 2002 Apr; 16(4):759-67. PubMed ID: 11929394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of alosetron on left colonic motility in non-constipated patients with irritable bowel syndrome and healthy volunteers.
    Clemens CH; Samsom M; Van Berge Henegouwen GP; Fabri M; Smout AJ
    Aliment Pharmacol Ther; 2002 May; 16(5):993-1002. PubMed ID: 11966509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prucalopride induces high-amplitude propagating contractions in the colon of patients with chronic constipation: a randomized study.
    Miner PB; Camilleri M; Burton D; Achenbach H; Wan H; Dragone J; Mellgard B
    Neurogastroenterol Motil; 2016 Sep; 28(9):1341-8. PubMed ID: 27270968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans.
    Bouras EP; Camilleri M; Burton DD; McKinzie S
    Gut; 1999 May; 44(5):682-6. PubMed ID: 10205205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of prucalopride on intestinal gas tolerance in patients with functional bowel disorders and constipation.
    Malagelada C; Nieto A; Mendez S; Accarino A; Santos J; Malagelada JR; Azpiroz F
    J Gastroenterol Hepatol; 2017 Aug; 32(8):1457-1462. PubMed ID: 28090679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of prucalopride, a new enterokinetic agent, on gastrointestinal transit and anorectal function in healthy volunteers.
    Poen AC; Felt-Bersma RJ; Van Dongen PA; Meuwissen SG
    Aliment Pharmacol Ther; 1999 Nov; 13(11):1493-7. PubMed ID: 10571606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-resolution manometry reveals different effect of polyethylene glycol, bisacodyl, and prucalopride on colonic motility in healthy subjects: An acute, open label, randomized, crossover, reader-blinded study with potential clinical implications.
    Corsetti M; Thys A; Harris A; Pagliaro G; Deloose E; Demedts I; Tack J
    Neurogastroenterol Motil; 2021 May; 33(5):e14040. PubMed ID: 33301221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of prucalopride in patients with constipation due to spinal cord injury.
    Krogh K; Jensen MB; Gandrup P; Laurberg S; Nilsson J; Kerstens R; De Pauw M
    Scand J Gastroenterol; 2002 Apr; 37(4):431-6. PubMed ID: 11989834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prucalopride, a systemic enterokinetic, for the treatment of constipation.
    Emmanuel AV; Roy AJ; Nicholls TJ; Kamm MA
    Aliment Pharmacol Ther; 2002 Jul; 16(7):1347-56. PubMed ID: 12144586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects and sites of action of a M1 receptor positive allosteric modulator on colonic motility in rats and dogs compared with 5-HT
    Tsukimi Y; Pustovit RV; Harrington AM; Garcia-Caraballo S; Brierley SM; Di Natale M; Molero JC; Furness JB
    Neurogastroenterol Motil; 2020 Aug; 32(8):e13866. PubMed ID: 32337809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral prucalopride in children with functional constipation.
    Winter HS; Di Lorenzo C; Benninga MA; Gilger MA; Kearns GL; Hyman PE; Vandeplassche L; Ausma J; Hoppenbrouwers M
    J Pediatr Gastroenterol Nutr; 2013 Aug; 57(2):197-203. PubMed ID: 23535761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prucalopride decreases esophageal acid exposure and accelerates gastric emptying in healthy subjects.
    Kessing BF; Smout AJ; Bennink RJ; Kraaijpoel N; Oors JM; Bredenoord AJ
    Neurogastroenterol Motil; 2014 Aug; 26(8):1079-86. PubMed ID: 24891067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised clinical trial: prucalopride, a colonic pro-motility agent, reduces the duration of post-operative ileus after elective gastrointestinal surgery.
    Gong J; Xie Z; Zhang T; Gu L; Yao W; Guo Z; Li Y; Lu N; Zhu W; Li N; Li J
    Aliment Pharmacol Ther; 2016 Apr; 43(7):778-89. PubMed ID: 26880227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A placebo-controlled trial of prucalopride for severe chronic constipation.
    Camilleri M; Kerstens R; Rykx A; Vandeplassche L
    N Engl J Med; 2008 May; 358(22):2344-54. PubMed ID: 18509121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prucalopride.
    Frampton JE
    Drugs; 2009; 69(17):2463-76. PubMed ID: 19911858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder.
    Bouras EP; Camilleri M; Burton DD; Thomforde G; McKinzie S; Zinsmeister AR
    Gastroenterology; 2001 Feb; 120(2):354-60. PubMed ID: 11159875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the enterokinetic prucalopride (R093877) on colonic motility in fasted dogs.
    Briejer MR; Prins NH; Schuurkes JA
    Neurogastroenterol Motil; 2001 Oct; 13(5):465-72. PubMed ID: 11696108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the 5-HT3 antagonist cilansetron vs placebo on phasic sigmoid colonic motility in healthy man: a double-blind crossover trial.
    Stacher G; Weber U; Stacher-Janotta G; Bauer P; Huber K; Holzäpfel A; Krause G; Steinborn C
    Br J Clin Pharmacol; 2000 May; 49(5):429-36. PubMed ID: 10792200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraluminal prucalopride increases propulsive motor activities via luminal 5-HT
    Shokrollahi M; Chen JH; Huizinga JD
    Neurogastroenterol Motil; 2019 Oct; 31(10):e13598. PubMed ID: 31012538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.